Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrathiomolybdate in primary biliary cholangitis
NCT00805805Phase 3Completed
- Start
- Apr 2006
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tetrathiomolybdate in primary biliary cholangitis (PBC). Primary endpoint: Liver function tests at 2 years. Started Apr 2006; status: completed.
02
Drugs
tetrathiomolybdate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT00805805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805805.